SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oxford GlycoSciences Plc -- Ignore unavailable to you. Want to Upgrade?


To: keokalani'nui who wrote (168)10/14/2001 6:21:34 PM
From: nigel bates  Read Replies (2) | Respond to of 469
 
I notice in the New Scientist that OGS is recruiting for "our recently formed therapeutic monoclonal antibody group... to determine the progress of novel human antibodies into man for clinical studies".
Sounds as though the MEDX collaboration (mentioned in the ad.) could be hotting up.
Couldn't find it on the website.

nig